Applications Open: HIV and Drug Abuse Prevention Research Ethics Training Institute (RETI)

Jan 16, 2020 | Kim Rodgers

Now in its ninth year, the Fordham HIV and Drug Abuse Prevention Research Ethics Training Institute (RETI) is a training grant sponsored by the National Institute on Drug Abuse. The RETI provides early career investigators in the social, behavioral, medical and public health fields with an opportunity to gain research ethics training. A major function of the RETI is also to conduct institute-funded research on ethical issues in HIV and drug use research. In doing so, RETI addresses the urgent need for HIV investigators who can identify and address ethical issues, engage drug-using and other at-risk communities in the construction and evaluation of population-sensitive research protections, and generate empirical data to inform ethical practice and policies for HIV prevention science. Through their funded Mentored Research Project (MRP), RETI fellows generate empirical data, publish their findings in a variety of high-impact academic journals, and are trained to apply for increasing grant opportunities.

RETI Aims

  • Expand fellows’ knowledge of and capacity to address key ethical issues in HIV prevention research with drug using and other at-risk communities
  • Provide fellows with the skills to ethically engage participants and communities in the construction of participant protections that reflect the values and merit the trust of all stakeholders in HIV and drug abuse prevention research
  • Increase fellows’ capacity to conduct research that will generate data to inform HIV and drug abuse prevention research practices and policies
  • Create and sustain an information and communication network for fellows, faculty and others in the field for enhancing ethical knowledge, ethical dialogue and future professional collaborations in HIV and drug abuse prevention research ethics

Selected applicants will:

  • Attend two summer training institutes with fully funded travel and lodging to New York City. The first institute will take place July 13-21, 2020, and the second will occur in July 2021
  • Receive a $30,000 grant to conduct a mentored research study that will contribute to evidence-based HIV & drug abuse research ethics practices
  • Join an international network of scholars examining current challenges in HIV & drug abuse research ethics

Learn more about the fellowship and application guidelines, and be sure to submit applications by March 11, 2020.


637020799465370000

About Kim Rodgers

Pronouns: She/Her

Kim Rodgers is the Communications Manager at NACCHO.

More posts by Kim Rodgers

Related Posts

Viral hepatitis logo
  • HIV, STI, & Viral Hepatitis

HHS Releases National Plan for Hepatitis Elimination

On January 7, 2021, the U.S. Department of Health and Human Services (HHS)...

Jan 19, 2021 | Kat Kelley

HHS Releases National Plan for Hepatitis Elimination

Si neisseria gonorrhoeae
  • Funding Opportunity
  • HIV, STI, & Viral Hepatitis

Funding Opportunity: Pharyngeal Gonorrhea Test of Cure...

NACCHO will fund up to 4 local health departments (LHDs) up to $100,000 each to...

Jan 19, 2021 | Rebekah Horowitz

Funding Opportunity: Pharyngeal Gonorrhea Test of Cure...

Doctor 563428 640
  • COVID-19
  • Health in All Policies
  • Leadership
  • Workforce Development

Preparing Your Local Health Department for the Future

If the pandemic has taught us one thing, it is the importance of preparedness....

Jan 15, 2021 | Guest Author

Preparing Your Local Health Department for the Future

Covid
  • COVID-19
  • Immunization

Dosing intervals for COVID-19 mRNA Vaccine

On January 6, CDC revised Interim Clinical Considerations for Use of mRNA...

Jan 14, 2021 | Beth Hess

Dosing intervals for COVID-19 mRNA Vaccine

Needleexchange 0
  • HIV, STI, & Viral Hepatitis

Join NACCHO’s SSP Monitoring & Evaluation Advisory Group

The National Association of County and City Health Officials (NACCHO), in...

Jan 07, 2021 | Kat Kelley

Join NACCHO’s SSP Monitoring & Evaluation Advisory Group

Shareable Vaccines
  • Immunization
  • Infectious Disease

NACCHO Partners with Mediaplanet for Its Vaccines...

New campaign emphasizes keeping up-to-date with routine vaccines.

Jan 07, 2021 | Andrea Grenadier

NACCHO Partners with Mediaplanet for Its Vaccines...

HIV COVID
  • COVID-19
  • HIV, STI, & Viral Hepatitis

COVID-19: Considerations for People with HIV

Updated resource discussing clinical and public health considerations related...

Jan 06, 2021 | Julia Zigman

COVID-19: Considerations for People with HIV

340 B stock photo
  • HIV, STI, & Viral Hepatitis

HHS Releases Advisory Opinion Clarifying that 340B...

A recent HHS statement clarifies that drug manufacturers are required to...

Jan 06, 2021 | Julia Zigman

HHS Releases Advisory Opinion Clarifying that 340B...

Hepatitis
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Knowledge, attitudes, and acceptability of direct-acting...

A recent study in PLOS One describes knowledge, attitudes, and acceptability of...

Jan 06, 2021 | Julia Zigman

Knowledge, attitudes, and acceptability of direct-acting...

Back to Top